Support for Laboratory Diagnosis and Monitoring to Scale Up and Improve HIV/AIDS Care and Treatment Services, and Strengthen Global Health Security for Caribbean Countries Supported under the President's Emergency Plan

The summary for the Support for Laboratory Diagnosis and Monitoring to Scale Up and Improve HIV/AIDS Care and Treatment Services, and Strengthen Global Health Security for Caribbean Countries Supported under the President's Emergency Plan grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control CGH, which is the U.S. government agency offering this grant.

Support for Laboratory Diagnosis and Monitoring to Scale Up and Improve HIV/AIDS Care and Treatment Services, and Strengthen Global Health Security for Caribbean Countries Supported under the President's Emergency Plan: The Award Ceiling for Year 1 is 0 (none). CDC anticipates an Approximate Total Fiscal Year Funding amount of $ 1,000,000 for Year 1, subject to the availability of funds.Access to high quality laboratory diagnostic services has a critical effect on the success of HIV treatment programs and is key to global health security. CDC has been providing targeted technical assistance (TA) to strengthen laboratory systems and services, with notable progress, including the accreditation of 6 public health laboratories in the Caribbean region. However, there is still a gap in having efficient and sustainable laboratory systems operating in a cost effective manner. Additional TA is needed to build strong, sustainable laboratory capacity and improve the provision of diagnostic and monitoring services for HIV, TB, STIs, and other emerging diseases of public health importance. This support will enhance the capacity for disease monitoring to assist with the scale up of HIV care and treatment programs and other diseases. This NOFO will focus on building and sustaining laboratory systems to support: access to quality-assured diagnostics, a competent workforce, laboratories with robust Quality Management Systems (QMS), implementation of the strengthening laboratory management toward accreditation (SLMTA) program, improvement of quality assurance (QA) and quality control (QC), timely access to quality testing services and results, disease surveillance and optimized and efficient national HIV and related testing laboratory networks.